---
$id: https://graph.org.ai/products/commodity/51442501
$type: Product
source: UNSPSC
code: "51442501"
title: "Mangafodipir"
class: "51442500"
classTitle: "Manganese-based radiopharmaceuticals, imaging agents, media, and tracers"
family: "51440000"
familyTitle: "Radiopharmaceuticals and contrast media"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mangafodipir

**UNSPSC Code**: 51442501
**Class**: [Manganese-based radiopharmaceuticals, imaging agents, media, and tracers](Manganese-based radiopharmaceuticals, imaging agents, media, and tracers.mdx)
**Family**: [Radiopharmaceuticals and contrast media](../Radiopharmaceuticals and contrast media.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a contrast media C22H26N4O14P2.H+.Mn.3Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 129FW80TG4, chemically known as mangafodipir trisodium, anhydrous, but more generally known as mangafodipir trisodium, which bears U.S. National Institutes of Health Compound Identifier 160036. European Medicines Agency schedules SUB12529MIGin its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12529MIG. Most nations schedule mangafodipir trisodium under HS 29333999 and SITC 51574. Mangafodipir trisodium bears US NLM identifiers UMLS ID C0067297 and NCI Concept Code C66053. SMILES: As of Q4 2014, MANGAFODIPIR TRISODIUM remains the US FDA Preferred Term for this commodity.

